To Repair a Broken Heart: Stem Cells in Ischemic Heart Disease

Area of Science:

• Regenerative Medicine
• Cardiovascular Research
• Stem Cell Biology

Background:

• Cardiovascular disease (CVD), particularly ischemic heart disease (IHD), causes significant global mortality.
• Current treatments for myocardial infarction (MI) often fail to fully restore lost cardiomyocyte function.
• Stem cells (SC) offer potential for cardiac tissue repair through direct replacement or paracrine signaling.

Purpose of the Study:

• To conduct a narrative review of experimental and clinical studies on stem cell therapies for infarcted myocardium.
• To focus on therapies administered via thoracic incision or percutaneous coronary intervention (PCI).
• To elucidate mechanisms of action and therapeutic effects of SC-based cardiac treatments.

Main Methods:

• Reviewed literature on stem cell applications in infarcted myocardium over the last two decades.
• Included studies using various stem cell types (ESCs, iPSCs, Muse, MSCs, CSCs).
• Focused on delivery methods including cell therapy and tissue-engineered (TE) constructs via surgical or interventional approaches.

Main Results:

• Various stem cell populations have been investigated for treating myocardial infarction (MI).
• Delivery methods include direct cell transplantation and tissue-engineered (TE) constructs.
• Therapeutic effects are achieved through direct cellular replacement and indirect paracrine mechanisms.

Conclusions:

• Stem cell therapies hold significant potential for treating ischemic heart disease (IHD) and regenerating cardiac tissue post-myocardial infarction (MI).
• Further research into delivery methods, such as surgical and interventional approaches, is crucial for optimizing therapeutic outcomes.
• Understanding the mechanisms of action is key to advancing stem cell-based cardiac regeneration.